June 29, 2017
CytomX Therapeutics
CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate
June 28, 2017
CytomX Therapeutics
CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 Trial
June 28, 2017
GBT
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)
June 27, 2017
Rhythm Pharmaceuticals
Rhythm and Camurus Announce Positive Initial Data for Extended-Release Delivery of Setmelanotide for the Treatment of Rare Genetic Disorders of Obesity
June 26, 2017
bluebird bio
bluebird bio Announces Topline Interim Clinical Data from Starbeam Study of Lenti-Dâ„¢ Drug Product in Cerebral Adrenoleukodystrophy (CALD)